SAN ANTONIO, Feb. 12, 2008 (PRIME NEWSWIRE) -- Sweet Success Enterprises (OTCBB:SWTS), the maker of GlucaSafe(tm) which supports healthy glucose levels announced today that its revolutionary beverage, GlucaSafe(tm), a tea and pomegranate based beverage with two grams of sugar and fifteen calories receives its complete results for its clinical trial on diabetes. The trial determined healthy glucose levels and long-term blood sugar control as evidenced by Hgb A1C measurements.
Dateline Roswell, Georgia; Howard A. Reisman MD announced the findings of the recently completed open label clinical trial involving the nutraceutical product, GlucaSafe(tm).
Dr. Reisman, a veteran clinical trial investigator with over 15 years of experience in the conduct of clinical trials for the Pharmaceutical Industry, enrolled 10 patients with a previous diagnosis of Type II non-insulin dependent Adult Onset Diabetes Mellitus. These patients were supplied with the nutraceutical beverage, GlucaSafe(tm) and were instructed to consume one standard serving of GlucaSafe(tm) two times a day for 12 consecutive weeks.
All 10 patients had a fasting serum glucose level drawn at baseline, upon entering the trial, which was then repeated at weeks one, two, three and twelve of the trial and Hemoglobin A1C levels were drawn upon enrolling in the trial and at the completion of the trial at 12 weeks.
Trial Results:
80% of the enrolled patients experienced a decrease in their serial serum fasting blood glucose measurements over the 12 week trial, the average decrease from baseline was 14%, with 2 of these patients experiencing a 27 and 60% decrease respectively.
70% of the enrolled patients experienced a decrease in their Hemoglobin A1C levels from baseline, the average decrease in these levels was 7 1/2 % with 2 of these patients experiencing a greater than 10% decrease.
As Hemoglobin A1C is a measurement of long term blood glucose control, it is the investigators opinion that a 6 month trial would reflect an even more dramatic decrease in Hemoglobin A1C levels.
Other studies done prior to this trial have indicated that certain ingredients used for the production of GlucaSafe(tm) assisted lowering blood pressure and cholesterol levels.
Product statements have not been evaluated by the FDA. The products are not intended to diagnose, treat, cure or prevent disease.
The Sweet Success Enterprises, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3428
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.